Heart Transplant Survival Outcomes for Adriamycin Dilated Cardiomyopathy

In 2015 there will be an estimated 11.3 million cancer survivors. With a growing population of cancer survivors, it is imperative to understand treatment options and outcomes for chemotherapy related cardiomyopathy. Anthracycline (AC) based chemotherapy causes heart failure (HF) in approximately 5%...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lenneman, Andrew J., Wang, Li, Wigger, Mark, Frangoul, Haydar, Harrell, Frank E., Silverstein, Cheri, Sawyer, Douglas B., Lenneman, Carrie G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563750/
https://ncbi.nlm.nih.gov/pubmed/23195041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2012.10.048
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi